Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | EYA2 | O00167 | 1/20 | 0.68 |
| ▸ | APP | P05067 | 1/20 | 0.68 |
| ▸ | ACE | P12821 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.65 |
| ▸ | DRD1 | P21728 | 1/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.65 |
| ▸ | DRD3 | P35462 | 1/20 | 0.65 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylenediamine SCHEMBL6094719 | 0.97 | TDP1 (0.65) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6290706 | 0.97 | TDP1 (0.74) | TDP1EYA2APPACEBLM | |
| Water SCHEMBL5155064 | 0.97 | TDP1 (0.65) | TDP1EYA2APPACEBLM | |
| Carbamic Acid SCHEMBL20546459 | 0.95 | TDP1 (0.62) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1686175 | 0.95 | TDP1 (0.70) | TDP1EYA2APPACEBLM | |
| SCHEMBL3416374 | 0.95 | TDP1 (0.75) | TDP1EYA2APPACEBLM | |
| SCHEMBL676801 | 0.94 | BLM (0.65) | TDP1EYA2APPACEBLM | |
| Hydrochloric Acid SCHEMBL9406491 | 0.92 | BLM (0.62) | TDP1EYA2APPACEBLM | |
| Acetamide SCHEMBL5491935 | 0.91 | TDP1 (0.56) | TDP1EYA2APPACEBLM | |
| SCHEMBL17177498 | 0.91 | TDP1 (0.56) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1817 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612343-B2 | PSMA binder and use thereof | Shiya Pharmaceutical, Inc (CN) | 2026-04-28 | — | — | US | claimed |
| US-20260102455-A1 | ANTIMICROBIAL HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL TECHNOLOGIES, LLC (US) | 2026-04-16 | — | — | US | claimed |
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| US-20250154437-A1 | CONCENTRATED FREE-FLOWING DETERGENT COMPOSITION HAVING IMPROVED PROPERTIES | HENKEL AG & CO. KGAA (DE) | 2025-05-15 | — | — | US | claimed |
| WO-2025087156-A1 | ETCHING COMPOSITION AND USE THEREOF | 安集微电子科技（上海）股份有限公司 | 2025-05-01 | — | — | WO | claimed |
| EP-3865534-B1 | METHOD FOR RECYCLING MATERIALS OBTAINED THROUGH GELIFICATION | UNIV DEGLI STUDI DI TRIESTE (IT) | 2025-03-12 | — | — | EP | claimed |
| WO-2025025335-A1 | NANOSTRUCTURED LOW-IMMUNOGENIC BIOLOGICAL ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD THEREFOR | 海迈医疗科技(苏州)有限公司 | 2025-02-06 | — | — | WO | claimed |
| US-20250003961-A1 | BASE MATERIAL FOR MANUFACTURING SENSOR FOR ANALYZING DETECTION TARGET, SENSOR FOR ANALYZING DETECTION TARGET, METHOD FOR ANALYZING DETECTION TARGET | UNIV KOBE NAT UNIV CORP (JP) | 2025-01-02 | — | — | US | claimed |
| EP-4479501-A1 | CONCENTRATED FREE-FLOWING DETERGENT COMPOSITION HAVING IMPROVED PROPERTIES | Henkel AG & Co. KGaA (DE) | 2024-12-25 | — | — | EP | claimed |
| US-12105085-B2 | Base material for manufacturing sensor for analyzing detection target, sensor for analyzing detection target, method for analyzing detection target | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2024-10-01 | — | — | US | claimed |
| EP-0349843-A2 | Composition and method of assaying aqueous liquids for specific gravity | MILES INC. (US) | 1990-01-10 | — | — | EP | claimed |
| US-4748105-A | Rapid bleach fixing of a silver halide color photographic light-sensitive material using an organic acid ferric complex | KONISIROKU PHOTO INDUSTRY COMPANY, LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0230090-A2 | Method for processing silver halide color photographic light-sensitive material | KONICA CORPORATION (JP) | 1987-07-29 | — | — | EP | claimed |
| EP-0213710-A2 | Method of processing silver halide color photographic material | KONICA CORPORATION (JP) | 1987-03-11 | — | — | EP | claimed |
| US-4563405-A | NONSTAINING, STORAGE STABLE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1986-01-07 | — | — | US | claimed |
| US-4559291-A | DIFFUSION TRANSFER ASSEMBLAGES USING REDOX DYE-RELEASERS, LIGUAND COMPETES FOR METAL TO METAL HYDROXIDE FORMATION | EASTMAN KODAK COMPANY (US) | 1985-12-17 | — | — | US | claimed |
| US-4285575-A | USING AN ELECTROCHROMIC ELECTROLYTE CONTAINING A CARBOXYLIC-CONTAINING COMPLEXING AGENT, A FERROUS SALT, A METAL SALT, AND A CHROMOGEN; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 1981-08-25 | — | — | US | claimed |
| US-4212518-A | ELECTROCHROMIC CELL | CANON KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| US-4051234-A | BIS-GUANIDINE COMPOUND, ETHYLENEDIAMINEDIACETIC ACID OR SALT AS CHELATOR | THE PROCTER & GAMBLE COMPANY (US) | 1977-09-27 | — | — | US | claimed |
| US-3984522-A | Method of removing nitrogen monoxide from a nitrogen monoxide-containing gas | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1976-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | RNASEH1, ACE2, DDX42 | TDP1 256/4885EYA2 1387/4885APP 810/4885 |
| US-20260102455-A1 | ANTIMICROBIAL HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF USING THE SAME | COL1A1, COL2A1, COL14A1 | TDP1 889/4885EYA2 4785/4885APP 1915/4885 |
| US-12612343-B2 | PSMA binder and use thereof | KLK3, AR, PSMA1 | TDP1 3187/4885EYA2 4543/4885APP 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.